BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4552815)

  • 1. Local tumor immunotherapy with in vitro activated autochithonous lymphocytes.
    Cheema AR; Hersh EM
    Cancer; 1972 Apr; 29(4):982-6. PubMed ID: 4552815
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of malignant tumors with spores of Clostridium butyricum M 55. 3. Therapeutic experiments on metastasizing tumors of various organs].
    Kretschmer H; Gläser A; Grässer A
    Arch Geschwulstforsch; 1972; 39(4):315-21. PubMed ID: 4560621
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of soluble factors released by the lymphocyte on tumorigenesis in man].
    May-Levin F; Graffte G; Brule G
    C R Acad Hebd Seances Acad Sci D; 1971 Jun; 272(23):2996-9. PubMed ID: 4997321
    [No Abstract]   [Full Text] [Related]  

  • 4. [Stimulation of cellular immunity in patients with malignant tumors].
    Govallo VI; Grigor'eva MP; Kosmiadi GA; Vostrikova NA
    Vopr Onkol; 1973; 19(12):30-4. PubMed ID: 4544936
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trials referral resource. NCI-sponsored trials of interleukin-6 (IL-6).
    Cheson BD; Carter CL; Sznol M
    Oncology (Williston Park); 1993 Jun; 7(6):43-4. PubMed ID: 8391298
    [No Abstract]   [Full Text] [Related]  

  • 6. [Utilization of soluble factors produced by lymphocytes as an adjuvant therapeutic method in malignant metastatic tumors. Preliminary results].
    May-Levin F; Graffte G; Brulé G
    Schweiz Med Wochenschr; 1972 Aug; 102(33):1188-90. PubMed ID: 5055040
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials of immunotherapy: present status.
    Morton DL; Goodnight JE
    Cancer; 1978 Nov; 42(5):2224-33. PubMed ID: 363256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary clinical results of antineoplastic immunotherapy associated with cytostatic treatments].
    Pederzini A; Guerra GP
    Boll Ist Sieroter Milan; 1971; 50(4):268-77. PubMed ID: 5163494
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials referral resource.
    Cheson BD; Ungerleider RS
    Oncology (Williston Park); 1992 Nov; 6(11):30, 32, 34-6. PubMed ID: 1332740
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Immunotherapy of malignant disease: the use of viable sensitized lymphocytes or transfer factor prepared from sensitized lymphocytes.
    Krementz ET; Mansell PW; Hornung MO; Samuels MS; Sutherland CA; Benes EN
    Cancer; 1974 Feb; 33(2):394-401. PubMed ID: 4360056
    [No Abstract]   [Full Text] [Related]  

  • 11. [5 years' experience in the immunotherapy of human cancer].
    Humphrey LJ; Boehm OR; Boehm BJ; Jewell WR
    Zentralbl Chir; 1973 Sep; 98(35):1241-6. PubMed ID: 4784998
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy from malignant disease.
    Goodnight JE; Morton DL
    Annu Rev Med; 1978; 29():231-83. PubMed ID: 348035
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy of human lung cancer with BCG cell-wall skeleton.
    Yasumoto K; Manabe H; Ueno M; Ohta M; Ueda H
    Gan; 1976 Dec; 67(6):787-95. PubMed ID: 798710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of cancer.
    Salmon SE; Jones SE
    Ariz Med; 1977 Jun; 34(6):396-8. PubMed ID: 880051
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy: the unfulfilled promise.
    Greco RS
    J Med Soc N J; 1981 Jan; 78(1):32-5. PubMed ID: 7021843
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Some aspects of the use of B.C.G. in the treatment of advanced malignant disease.
    Grant RM; Mackie RM; Cochran AJ; Hoyle D; Ross C
    Br J Cancer; 1974 Aug; 30(2):182. PubMed ID: 4471590
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotherapy as an adjunct to surgery in the treatment of cancer.
    Eilber FR; Holmes EC; Morton DL
    World J Surg; 1977 Sep; 1(5):547-54. PubMed ID: 602232
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy of human tumors.
    Sinkovics JG
    Pathobiol Annu; 1978; 8():241-84. PubMed ID: 364375
    [No Abstract]   [Full Text] [Related]  

  • 19. BCG as adjuvant immunotherapy for neoplasia.
    Hersh EM; Gutterman JU; Mavligit GM
    Annu Rev Med; 1977; 28():489-515. PubMed ID: 324372
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological response in patients receiving Corynebacterium parvum therapy.
    Osborn DE; Castro JE
    Clin Oncol; 1977 Jun; 3(2):155-64. PubMed ID: 872468
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.